Texas Capital Bank Wealth Management Services Inc purchased a new position in shares of Aflac Incorporated (NYSE:AFL – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 6,830 shares of the financial services provider’s stock, valued at approximately $801,000.
Several other hedge funds also recently made changes to their positions in the business. Quarry LP bought a new stake in shares of Aflac in the fourth quarter worth $25,000. Groupe la Francaise acquired a new position in Aflac during the first quarter worth $25,000. Whipplewood Advisors LLC bought a new position in Aflac in the first quarter valued at $25,000. Nalls Sherbakoff Group LLC bought a new position in Aflac in the fourth quarter valued at $29,000. Finally, Evergreen Advisors LLC acquired a new stake in Aflac in the 1st quarter valued at $29,000. 67.44% of the stock is owned by institutional investors.
Aflac Stock Performance
Shares of AFL opened at $120.95 on Tuesday. The company has a market cap of $60.64 billion, a PE ratio of 12.96, a price-to-earnings-growth ratio of 1.96 and a beta of 0.60. The firm has a 50-day moving average of $121.47 and a 200-day moving average of $115.95. Aflac Incorporated has a one year low of $104.66 and a one year high of $130.22. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.12 and a quick ratio of 0.12.
Aflac Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Wednesday, August 19th will be given a $0.61 dividend. This represents a $2.44 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend is Wednesday, August 19th. Aflac’s dividend payout ratio (DPR) is presently 26.15%.
Insider Activity at Aflac
In related news, major shareholder Post Holdings Co. Ltd. Japan sold 63,000 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $118.12, for a total transaction of $7,441,560.00. Following the transaction, the insider directly owned 51,169,435 shares of the company’s stock, valued at approximately $6,044,133,662.20. The trade was a 0.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 541,333 shares of company stock worth $63,345,006. Insiders own 0.80% of the company’s stock.
Analyst Ratings Changes
Several brokerages have commented on AFL. UBS Group reissued a “neutral” rating and set a $124.00 price target (up from $114.00) on shares of Aflac in a research report on Wednesday, July 8th. Barclays restated an “underweight” rating and issued a $99.00 price objective (up from $98.00) on shares of Aflac in a report on Friday, August 7th. Wall Street Zen downgraded Aflac from a “hold” rating to a “sell” rating in a research report on Saturday. JPMorgan Chase & Co. dropped their target price on Aflac from $117.00 to $116.00 and set a “neutral” rating on the stock in a report on Tuesday, August 11th. Finally, Weiss Ratings cut Aflac from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $117.58.
Get Our Latest Research Report on AFL
Aflac Profile
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Read More
- Five stocks we like better than Aflac
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
